Novoseven

List of products in the National Drug Code with proprietary name novoseven. This medication is used to treat and prevent bleeding in people with certain conditions (such as hemophilia type A or B, low levels of factor VII, Glanzmann's thrombasthenia). People with these conditions are at risk for bleeding longer after an injury/surgery and for bleeding inside the body (especially into the joints and muscles). This product contains a man-made form of factor VIIa, which is a protein (clotting factor) in the blood that works with other clotting factors to help the blood clot and therefore stop bleeding.

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Labeler Name Product Type
0169-7010Novoseven RTCoagulation Factor Viia (recombinant)KitNovo NordiskPlasma Derivative
0169-7020Novoseven RTCoagulation Factor Viia (recombinant)KitNovo NordiskPlasma Derivative
0169-7040Novoseven RTCoagulation Factor Viia (recombinant)KitNovo NordiskPlasma Derivative
0169-7050Novoseven RTCoagulation Factor Viia (recombinant)KitNovo NordiskPlasma Derivative
0169-7201Novoseven RTCoagulation Factor Viia (recombinant)KitNovo NordiskPlasma Derivative
0169-7202Novoseven RTCoagulation Factor Viia (recombinant)KitNovo NordiskPlasma Derivative
0169-7205Novoseven RTCoagulation Factor Viia (recombinant)KitNovo NordiskPlasma Derivative
0169-7208Novoseven RTCoagulation Factor Viia (recombinant)KitNovo NordiskPlasma Derivative